Alvotech And Stada Scoop First EU Stelara Biosimilar
As CHMP Also Endorses Ranibizumab Biosimilar, Azacitidine And Paclitaxel Generics
Stada and Alvotech’s Uzpruvo ustekinumab biosimilar is set to become the EU’s first approved rival to Stelara after the EMA’s CHMP issued a positive opinion for the product. Meanwhile, the committee also endorsed a Lucentis biosimilar from Qilu Pharma as well as azacitidine and paclitaxel generics from Fresenius Kabi and Accord.
